Breast MRI screening for average‐risk women: A monte carlo simulation cost–benefit analysis
- 11 January 2019
- journal article
- research article
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 49 (7) , e216-e221
Abstract
Background: Screening high‐risk women for breast cancer with MRI is cost‐effective, with increasing cost‐effectiveness paralleling increasing risk. However, for average‐risk women cost is considered a major limitation to mass screening with MRI.Purpose: To perform a cost–benefit analysis of a simulated breast cancer screening program for average‐risk women comparing MRI with mammography.Study Type: Population simulation study.Population/Subjects: Five million (M) hypothetical women undergoing breast cancer screening.Field Strength/Sequence: Simulation based primarily on Kuhl et al8 study utilizing 1.5T MRI with an axial bilateral 2D multisection gradient‐echo dynamic series (repetition time / echo time 250/4.6 msec; flip angle, 90°) with a full 512 × 512 acquisition matrix and a sensitivity encoding factor of two, performed prior to and four times after bolus injection of 0.1 mmol of gadobutrol per kg of body weight (Gadovist; Bayer, Germany). An axial T2‐weighted fast spin‐echo sequence with identical anatomic parameters was also included.Assessment: A Monte Carlo simulation utilizing Medicare reimbursement rates to calculate input variable costs was developed to compare 5M women undergoing breast cancer screening with either triennial MRI or annual mammography, 2.5M in each group, over 30 years.Statistical Tests: Expected recall rates, BI‐RADS 3, BI‐RADS 4/5 cases and cancer detection rates were determined from published literature with calculated aggregate costs including resultant diagnostic/follow‐up imaging and biopsies.Results: Baseline screening of 2.5M women with breast MRI cost $1.6 billion (B), 3× higher than baseline mammography screening ($0.54B). With subsequent screening, MRI screening is more cost‐effective than mammography screening in 24 years ($13.02B vs. $13.03B). MRI screening program costs are largely driven by cost per MRI exam ($549.71). A second simulation model was performed based on MRI Medicare reimbursement trends using a lower MRI cost ($400). This yielded a cost‐effective benefit compared to mammography screening in less than 6 years ($3.41B vs. $3.65B), with over a 22% cost reduction relative to mammography screening in 12 years and reaching a 38% reduction in 30 years.Data Conclusion: Despite higher initial cost of a breast MRI screening program for average‐risk women, there is ultimately a cost savings over time compared with mammography. This estimate is conservative given cost–benefit of additional/earlier breast cancers detected by breast MRI were not accounted for.Level of Evidence: 3Technical Efficacy Stage: 6J. Magn. Reson. Imaging 2019.Keywords
Funding Information
- MSK Cancer Center Support Grant/Core Grant (P30 CA008748)
This publication has 33 references indexed in Scilit:
- ACR Appropriateness Criteria Breast Cancer ScreeningJournal of the American College of Radiology, 2013
- Detection of Breast Cancer With Addition of Annual Screening Ultrasound or a Single Screening MRI to Mammography in Women With Elevated Breast Cancer RiskJAMA, 2012
- Use of BI-RADS 3–Probably Benign Category in the American College of Radiology Imaging Network Digital Mammographic Imaging Screening TrialRadiology, 2011
- Cost Effectiveness of Breast Cancer Screening With Contrast-Enhanced MRI in High-Risk WomenJournal of the American College of Radiology, 2009
- Productivity Costs of Cancer Mortality in the United States: 2000–2020JNCI: Journal of the National Cancer Institute, 2008
- MR state of the artEuropean Journal of Radiology, 1998
- Contrast-enhanced MRI of the breast: accuracy, value, controversies, solutionsEuropean Journal of Radiology, 1997
- Sensitivity and Specificity of MR Mammography with Histopathological Correlation in 250 BreastsActa Radiologica, 1996
- The Monte Carlo MethodJournal of the American Statistical Association, 1949
- The Monte Carlo MethodJournal of the American Statistical Association, 1949